Sharpen your basketballs, pencil fans!

Earnings call Exelixis delivered strong Q1 2026 results, with total revenues up 8% YoY to $611 million and U.S. CABOMETYX net product revenues rising to $555 million. Management reiterated full-year ...

Learn how to create a detailed Deadpool sketch with this fun Marvel character drawing tutorial. Follow the artistic process ...

Multi-cancer early detection (MCED) test company Grail (GRAL 5.00%) has some very high-profile backers. None other than ...

With a new cancer treatment, "patients who couldn't tolerate a major operation now have another option," a doctor tells ...

Researchers found that around one in ten patients with ‘psychosomatic’ conditions actually had underlying physical illnesses ...

GLP-1 medications have transformed the way doctors treat obesity in adults — but as demand grows, a new question is emerging: ...

A growing form of donation is expanding the organ supply in the US — and testing how medicine protects dying patients.

Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping a healthy pancreas in detail down to the cellular level, they discovered ...

Experts say that the increasing interest in weight-loss drugs such as GLP-1 reflects broader anxieties around body image and self-worth, further magnified by social media and constant exposure to ...

Premium Bonds are one of the country’s most popular savings products, with more than £135 billion saved in them. Premium Bonds differ from traditional savings accounts as bondholders are not ...